scholarly article | Q13442814 |
P356 | DOI | 10.2463/MRMS.7.23 |
P698 | PubMed publication ID | 18460845 |
P50 | author | Masamitsu Hatakenaka | Q45396143 |
H Honda | Q88632968 | ||
P2093 | author name string | Yoshio Matsuo | |
Yoshinao Oda | |||
Masazumi Tsuneyoshi | |||
Hidetake Yabuuchi | |||
Hiroyasu Soeda | |||
Takeshi Kamitani | |||
P433 | issue | 1 | |
P304 | page(s) | 23-29 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine | Q26842414 |
P1476 | title | Apparent diffusion coefficients of breast tumors: clinical application. | |
P478 | volume | 7 |
Q41292151 | A pilot evaluation of magnetic resonance imaging characteristics seen with solid papillary carcinomas of the breast in 4 patients |
Q53187901 | A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? |
Q53121836 | An intraoperative MRI system for margin assessment in breast conserving surgery: Initial results from a novel technique. |
Q37328026 | Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer |
Q53076800 | Apparent diffusion coefficient as a potential surrogate marker for Ki-67 index in mucinous breast carcinoma. |
Q51546104 | Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy. |
Q30730091 | Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy |
Q38018542 | Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review |
Q36839178 | Apparent diffusion coefficient value in invasive ductal carcinoma at 3.0 Tesla: is it correlated with prognostic factors? |
Q35614931 | Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI |
Q48115092 | Associations among q-space MRI, diffusion-weighted MRI and histopathological parameters in meningiomas |
Q33965703 | Breast MR with special focus on DW-MRI and DCE-MRI |
Q38234778 | Clinical evaluation and management of benign soft tissue tumors of the extremities |
Q34757933 | Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation |
Q34097311 | Comparisons of multi b-value DWI signal analysis with pathological specimen of breast cancer |
Q34361556 | Conspicuity of breast lesions at different b values on diffusion-weighted imaging |
Q41709190 | Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis |
Q87984148 | Correlation between electrical conductivity and apparent diffusion coefficient in breast cancer: effect of necrosis on magnetic resonance imaging |
Q33760804 | Correlation of Prognostic Factors of Invasive Lobular Carcinoma with ADC Value of DWI and SUVMax of FDG-PET |
Q44247897 | Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients |
Q36653229 | Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer |
Q46796620 | Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla |
Q37538876 | Diagnosis of breast masses from dynamic contrast-enhanced and diffusion-weighted MR: a machine learning approach. |
Q42122502 | Diagnostic Value of Diffusion-weighted Imaging and Apparent Diffusion Coefficient Values in the Differentiation of Breast Lesions, Histpathologic Subgroups and Correlatıon with Prognostıc Factors using 3.0 Tesla MR |
Q33677899 | Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols |
Q38219736 | Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesions. |
Q94570799 | Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: A systematic review and meta-analysis |
Q33857530 | Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study |
Q35083961 | Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging |
Q53829468 | Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer. |
Q42139166 | Diffusion tensor imaging of breast lesions: evaluation of apparent diffusion coefficient and fractional anisotropy and tissue cellularity |
Q84612704 | Diffusion tensor magnetic resonance imaging of the breast: a pilot study |
Q38009677 | Diffusion tensor magnetic resonance imaging of the normal breast: reproducibility of DTI-derived fractional anisotropy and apparent diffusion coefficient at 3.0 T. |
Q53561619 | Diffusion weighted imaging and apparent diffusion coefficient in 3 tesla magnetic resonance imaging of breast lesions. |
Q37087591 | Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. |
Q51833677 | Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. |
Q83479168 | Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques |
Q52986909 | Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors. |
Q36237072 | Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma |
Q50308589 | Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis |
Q51830723 | Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. |
Q33823280 | Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions |
Q44736400 | Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study |
Q82454963 | Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation |
Q88017670 | Diffusion-weighted magnetic resonance imaging of breast lesions: the influence of different fat-suppression techniques on quantitative measurements and their reproducibility |
Q55624869 | Discrimination of malignant and benign breast masses using automatic segmentation and features extracted from dynamic contrast-enhanced and diffusion-weighted MRI. |
Q34951384 | Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy |
Q30896010 | Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis |
Q42979883 | FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion |
Q53027160 | Fat suppression techniques (STIR vs. SPAIR) on diffusion-weighted imaging of breast lesions at 3.0 T: preliminary experience. |
Q30474460 | Functional magnetic resonance: biomarkers of response in breast cancer |
Q41005538 | Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma. |
Q35447075 | Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. |
Q38960247 | Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer |
Q35093223 | Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI. |
Q47817346 | Is the necrosis/wall ADC ratio useful for the differentiation of benign and malignant breast lesions? |
Q89847109 | MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses |
Q38202564 | MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies |
Q53062797 | Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of diffusion-weighted imaging in the differential diagnosis? |
Q33873362 | Magnetic resonance in the detection of breast cancers of different histological types |
Q85259257 | Mediastinal paraganglioma |
Q33781446 | Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions |
Q37593722 | Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study. |
Q37776141 | Molecular and Functional Imaging of Breast Cancer |
Q34380422 | Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRI |
Q57181772 | Non-Invasive Quantification of Cell Density in 3D Gels by MRI |
Q63990402 | Noninvasive Quantification of Cell Density in Three-Dimensional Gels by MRI |
Q36417710 | Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging |
Q54176725 | Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement. |
Q36925030 | Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer. |
Q35860283 | Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases |
Q43114082 | Qualitative and quantitative diffusion-weighted imaging of the breast at 3T - A useful adjunct to contrast-enhanced MRI in characterization of breast lesions |
Q36689284 | Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations |
Q34155874 | Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity |
Q53088793 | Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer. |
Q36317605 | Role of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient values in the detection of gastric carcinoma |
Q84948712 | Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions |
Q49499170 | Stromal fibrosis: imaging features with diagnostic contribution of diffusion weighted MR imaging. |
Q57742687 | The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T |
Q37297789 | The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis |
Q50984483 | The diagnostic value of diffusion-weighted imaging and the apparent diffusion coefficient values in the differentiation of benign and malignant breast lesions. |
Q43275527 | The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. |
Q33814091 | The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. |
Q58604567 | Two Different Methods of Region-of-Interest Placement for Differentiation of Benign and Malignant Breast Lesions by Apparent Diffusion Coefficient Value |
Q84590317 | Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment |
Q36983703 | Value of Apparent Diffusion Coefficient Values in Differentiating Malignant and Benign Breast Lesions |
Q84951684 | Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions |
Q53292844 | [Diffusion-weighted MR imaging of the breast] |
Q53077782 | [Diffusion-weighted breast imaging. Clinical implementation procedure]. |
Search more.